Exelixis
EXEL
#1729
Rank
โ‚ฌ10.18 B
Marketcap
37,98ย โ‚ฌ
Share price
-0.36%
Change (1 day)
19.74%
Change (1 year)
Exelixis, Inc. is an American genomics-based drug discovery company and the producer of Cometriq, a treatment for medullary thyroid cancer.

Stock price history for Exelixis (EXEL)

Highest end of day price: 42,63ย โ‚ฌ Euro on 2000-07-26

Lowest end of day price: 1,12ย โ‚ฌ Euro on 2014-12-24

Stock price history of Exelixis from 2000 to 2026

Annual Stock Price Performance

Year Performance
2026 0.11%
2025 29.14%
2024 39.16%
2023 47.18%
2022-16.37%
2021-10.96%
2020 13.65%
2019-11.59%
2018-37.36%
2017 106.38%
2016 171.58%
2015 241.82%
2014-76.70%
2013 26.92%
2012-1.93%
2011-44.24%
2010 9.47%
2009 41.19%
2008-42.56%
2007-8.87%
2006-7.60%
2005 2.39%
2004 35.71%
2003-7.24%
2002-49.40%
2001 31.00%
2000-0.85%

Stock price for similar companies or competitors

Company Stock price Change 1d% Country
210,35ย โ‚ฌ-0.44%๐Ÿ‡บ๐Ÿ‡ธ USA
24,51ย โ‚ฌ-0.81%๐Ÿ‡บ๐Ÿ‡ธ USA
301,14ย โ‚ฌ-1.51%๐Ÿ‡บ๐Ÿ‡ธ USA
41,45ย โ‚ฌ 0.34%๐Ÿ‡ซ๐Ÿ‡ท France
104,61ย โ‚ฌ 0.02%๐Ÿ‡บ๐Ÿ‡ธ USA
51,58ย โ‚ฌ-2.45%๐Ÿ‡บ๐Ÿ‡ธ USA
49,07ย โ‚ฌ 1.25%๐Ÿ‡ฌ๐Ÿ‡ง UK
0,48ย โ‚ฌ 3.17%๐Ÿ‡บ๐Ÿ‡ธ USA
12,98ย โ‚ฌ 0.00%๐Ÿ‡บ๐Ÿ‡ธ USA